ESMO Congress 2022 - Biognosys

ESMO Congress 2022

At this year’s ESMO Congress, Biognosys was proud to present 2 poster presentations:

Poster Presentations

Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis

Presenter: Domenico Mallardo (Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy)

Poster presented at ESMO 2022

READ MORE

PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients

Presenter: Mitchell P. Levesque (University of Zurich, Switzerland)

Poster presented at ESMO 2022

READ MORE

Do not hesitate to contact our scientific experts at services@biognosys.com to discuss how our proteomics solutions can support your oncology research with transformative insights from discovery to clinic.

Stay Tuned for Future Events

Contact